期刊文献+

TSP-1、Survivin、VEGF表达在骨肉瘤肺转移中的意义 被引量:4

Clinical Significance of Expressions of TSP-1,Survivin and VEGF in Osteosarcoma with Lung Metastasis
暂未订购
导出
摘要 目的:研究TSP-1、Survivin、VEGF在骨肉瘤组织中的表达,探讨其与骨肉瘤肺转移的关系。方法:运用免疫组织化学S-P法,检测41例骨肉瘤病例中TSP-1、Survivin、VEGF的表达。结果:①TSP-1、Survivin和VEGF在41例骨肉瘤组织中阳性表达率程度不同。②三者在骨肉瘤组织中的阳性表达与患者的性别、年龄、肿瘤的大小、肿瘤部位、组织学类型、发病时间等因素无相关性(P>0.05),但与是否肺转移显著相关(P<0.05)。③TSP-1与Survivin呈负相关性(r=-0.467,P<0.05);TSP-1与VEGF呈负相关性(r=-0.504,P<0.05)。结论:TSP-1、Survivin和VEGF在骨肉瘤中有着不同程度的表达,与骨肉瘤的发生发展,并与骨肉瘤肺转移密切相关;TSP-1的表达与Survivin、VEGF的表达亦密切相关。 Objective: To study the expressions of TSP-1, Survivin and VEGF in tissues of osteosarcoma and its association with lung metastasis. Method: Expressions of TSP-1, Survivin and VEGF were detected with immunohistochemical staining (SP method) in 41 cases. Result: Positive expression rates of TSP-1, Survivin and VEGF in tissues of osteosarcoma were different. Positive expressions of TSP-1, Survivin and VEGF showed no relevance to the gender, age, the size and location of tumor, types of tissue and onset time (P〉0.05), but had close relevance to lung metastasis (P〈0.05). TSP-1 and Survivin suggested a negative correlation (r=-0.467, P〈0.05); TSP-1 and VEGF also did (r=-0.467, P〈0.05). Conclusion: Expressions ofTSP-1, Survivin and VEGF are different in osteosarcoma and have close associations to the development of osteosarcoma and lung metastasis; expression of TSP-1 is closely related to expressions of Survivin and VEGF.
出处 《西部中医药》 2012年第6期102-105,共4页 Western Journal of Traditional Chinese Medicine
基金 甘肃省技术研究与开发专项计划项目(编号0709TCYA027)
关键词 骨肉瘤 TSP-1 SURVIVIN VEGF 肺转移 osteosarcoma TSP-1 Survivin VEGF lung metastasis
  • 相关文献

参考文献15

  • 1Roberts DD,Isenberg JS,Ridnour LA. Nitric oxide and its gatekeeper thrombospondin-1 in tnmor angiogenesis[J].Clinical Cancer Research,2007,(03):795-798.
  • 2Naumov GN,Akslen LA,Folkman J. Role of angiogenesis in human tumor dormancy:animal models of the angiogenie switch[J].Cell Cycle,2006,(16):1779-1787.
  • 3Rice AJ,StewardMA. Quinn CKThrombospondin-1 protein expression relates to good prognostic indices in dutal carcinoma in situ of the breast[J].Journal of Clinical Pathology,2002,(12):921-925.
  • 4Miyanaga K,Kato Y,Nakamura T. Expression and role of thrombospondin-1 in colorectal cancer[J].Anticancer Research,2002,(6C):3941-3948.
  • 5Kasper HU,Ebert M,Malfertheiner P. Expression of thrombospondin-1 in pancreatic carcinoma:correlation with microvessel density[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2001,(02):116-120.
  • 6Tsraboletti G,Morbidelli L,Donnini S. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells[J].Federation of America Societies for Experimental Biology Journal,2000,(12):1674-1676.
  • 7Sargiannidou I,Zhou J,Tuszynski GP. The role of thrombospondin-1 in tumor progression[J].Experimental Biology and Medicine,2001,(08):726-733.
  • 8O′Connor DS,Schechner JS,Adida C. Control of apoptosis during angiogenesis by survivin expression in endothelial celi[J].American Journal of Pathology,2000,(02):393-398.
  • 9Bao R,Connolly DC,Murphy M. Activation of cancer-specific gene expression by the survivin promoter[J].Journal of the National Cancer Institute,2002,(07):522-528.
  • 10Conway EM,Pollefeyt S,Cornelissen J. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic function[J].Blood,2000,(04):1435-1442.

二级参考文献7

  • 1Brown LF, Brase B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in breast cancer[ J]. Anticancer Res, 1998,18:441 ~450.
  • 2Volm M,Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor FLT-1 in squamous cell lung cancer [J]. Int J Cancer, 1997,74 ( 1 ) :64 ~ 68.
  • 3Hatva E, Bohling T, Janskelainen J, et al. Vascular growth factor and receptors in capillary hemangiobblastomas and hemangiopericytomas [J]. Am J Pathl,1996,148(3) :763 ~767.
  • 4Cornali E, Zietz C, Benelli R, et al. Vascular growth factor regulates angiogenesis and vascular permeability in kaposis sarcoma[ J ]. Am J Pathol,1996,149(6) :1851 ~ 1859.
  • 5Asai T,Vada T,Itoh K, et al. Establishment and characterization of a muring osteosarcoma cell line ( Lm8 ) with high metastatic potential to the lung[ J ]. Int J Cancer, 1998,76:3418 ~ 3425.
  • 6Mori S,Veda T,Kruatsn S,et al. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma [ J ]. Int Jcancer, 1995,61:1148 ~ 1153.
  • 7Gordon M,Margolin K,Talpaz M,et al. Phase 1 safety and pharmacokinetic study of recombinant human anti-vascular growth factor in patients with advanced cancer[ J ]. J Clin Oncol, 2001,19 ( 3 ): 843 ~850.

共引文献9

同被引文献72

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部